Vicore Pharma Holding AB | Balance Sheet
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
14,025.00
1,710.00
25,175.00
4,266.00
24,019.00
Total Accounts Receivable
587.00
239.00
1,167.00
345.00
543.00
Other Current Assets
155.00
146.00
4.00
188.00
163.00
Total Current Assets
14,767.00
2,095.00
26,346.00
4,799.00
24,725.00
Net Property, Plant & Equipment
95.00
58.00
8.00
2.00
28.00
Total Investments and Advances
8,505.00
20,110.00
20,110.00
20,610.00
22,745.00
Intangible Assets
27,613.00
37,105.00
42,761.00
56,239.00
72,029.00
Total Assets
50,980.00
59,368.00
89,225.00
81,650.00
119,527.00
ST Debt & Current Portion LT Debt
-
1,500.00
-
-
-
Accounts Payable
690.00
562.00
2,312.00
2,184.00
2,780.00
Income Tax Payable
-
-
126.00
86.00
143.00
Other Current Liabilities
1,203.00
1,632.00
2,879.00
1,805.00
1,658.00
Total Current Liabilities
1,893.00
3,694.00
5,317.00
4,075.00
4,581.00
Deferred Taxes
1,978.00
1,978.00
1,978.00
1,978.00
1,978.00
Other Liabilities
7,100.00
-
-
-
-
Total Liabilities
10,971.00
5,672.00
7,295.00
6,053.00
6,559.00
Common Equity (Total)
40,009.00
53,696.00
81,930.00
75,597.00
112,968.00
Total Shareholders' Equity
40,009.00
53,696.00
81,930.00
75,597.00
112,968.00
Total Equity
40,009.00
53,696.00
81,930.00
75,597.00
112,968.00
Liabilities & Shareholders' Equity
50,980.00
59,368.00
89,225.00
81,650.00
119,527.00
About Vicore Pharma Holding AB
View Profile
